Hapten‐directed spontaneous disulfide shuffling: a universal technology for site‐directed covalent coupling of payloads to antibodies

Abstract

Humanized hapten-binding IgGs were designed with an accessible cysteine close to their binding pockets, for specific covalent payload attachment. Individual analyses of known structures of digoxigenin (Dig)- and fluorescein (Fluo) binding antibodies and a new structure of a biotin (Biot)-binder, revealed a “universal” coupling position (52+2) in proximity to binding pockets but without contributing to hapten interactions. Payloads that carry a free thiol are positioned on the antibody and covalently linked to it via disulfides. Covalent coupling is achieved and driven toward complete (95–100%) payload occupancy by spontaneous redox shuffling between antibody and payload. Attachment at the universal position works with different haptens, antibodies, and payloads. Examples are the haptens Fluo, Dig, and Biot combined with various fluorescent or peptidic payloads. Disulfide-bonded covalent antibody-payload complexes do not dissociate in vitro and in vivo. Coupling requires the designed cysteine and matching payload thiol because payload or antibody without the Cys/thiol are not linked (<5% nonspecific coupling). Hapten-mediated positioning is necessary as hapten-thiol-payload is only coupled to antibodies that bind matching haptens. Covalent complexes are more stable in vivo than noncovalent counterparts because digoxigeninylated or biotinylated fluorescent payloads without disulfide-linkage are cleared more rapidly in mice (approximately 50% reduced 48 hour serum levels) compared with their covalently linked counterparts. The coupling technology is applicable to many haptens and hapten binding antibodies (confirmed by automated analyses of the structures of 140 additional hapten binding antibodies) and can be applied to modulate the pharmacokinetics of small compounds or peptides. It is also suitable to link payloads in a reduction-releasable manner to tumor- or tissue-targeting delivery vehicles.—Dengl, S., Hoffmann, E., Grote, M., Wagner, C., Mundigl, O., Georges, G., Thorey, I., Stubenrauch, K.-G., Bujotzek, A., Josel, H.-P., Dziadek, S., Benz, J., Brinkmann, U. Hapten-directed spontaneous disulfide shuffling: a universal technology for site-directed covalent coupling of payloads to antibodies.

VH-VL orientation prediction for antibody humanization candidate selection: A case study

“…22 For each Fv structure involved, the ABangle parameters were measured and the orientation fingerprint consisting of 54 residues was generated. 44 To ensure to include the maximum diversity of different orientation fingerprints in the training set, we used CD-HIT 45,46 to cluster the orientation fingerprints at 100% identity, and, for each cluster, added at least one representative to the training set, until ⅔ of the available structures had been assigned to the training set. The remaining ⅓ were used for testing.…”

Site-Specific Dual Antibody Conjugation via Engineered Cysteine and Selenocysteine Residues

“…During expression, the engineered Cys residues in THIOMAB are usually capped with a cysteine, a glutathione, or a homocysteine through a disulfide bond 11, 22 . This may also apply to engineered Sec residues in SELENOMAB.…”

MoFvAb: Modeling the Fv region of antibodies

“…The CDR-H3 of crystal structure 5BMF forms one side of a hydrophobic cage for its antigen, the small molecule theophylline, in this case prolonged by a linker for covalent coupling. 48 Among the key players of the interaction are W351/ H95, which realizes p-stacking interactions with the xanthine moiety of theophylline, and F397/H99, which contributes to the bottom of the cage (Fig. SI5).…”